Page 289 - DOENÇA MENINGOCÓCICA - VOLUME 2 - DIGITAL
P. 289

158) GOTSCHLICH, E. C.  Unresolved problems in the prevention of meningococcal
                meningitis. In: BEERS, Jr, R. F. & BASSOTT, E. F. - The role of immunological factors in
                infections allergic and auto immune processes. New York, Haven Press, 1976.

                159) GREENHOOD, B. M. ONYEWOTU, II. & WHITILLE, H. C. Complement and
                meningococcal infection. Br. Med. J., London, 1: 797-799, 1976.

                160) FINLEY, R. A. Prophylaxis against meningococcal disease. JAMA, Chicago, 236: 459-
                461, 1976.
                161) GRIFISS, J. M. & ARTENSTEIN, M. S. The ecology of the genus Neisseria. Mt. Sinai
                J. Med., New York, 43: 746-761, 1976.

                162) JACOBSON, J. A.; CAMARGO, P. A. M.; FERREIRA, J. T. & MC CORMICK, J. N.
                The risk of meningitis among classroom contacts during an epidemic of meningococcal
                disease. Am. J. Epidemiol, IOWA, 104: 552-555, 1976.

                163) JONES, D. M. & TOBIN, B. M. Serotypes of group B meningococci. J. Clin. Pathol.,
                London, 29: 746-748, 1976.

                164) LIMA, M. L. R.; MARZOCHI, K. B. F.; TAKAOKA, L.; PASSOS., S. N.; BALDY, J. L. S. &
                TAKATA, P. Estudo comparativo da evolução clínica e laboratorial da doença meningocócica
                em indivíduos que receberam e que não receberam a vacina antimeningocócica. Londrina,
                1976. Trabalho apresentado no 29º Congresso da Associação Médica de Londrina. (mimeo).
                165) Meningococcal Disease Surveillance Group, 1974. Meningococcal disease. Secondary
                attack rate and chemoprophylaxis in the United States, 1974. JAMA, Chicago, 235: 261-
                265, 1976.
                166)  OMS.  Informe  de  um  grupo  de  estudio  de  la  OMS.  Lucha  contra  la  meningites
                cerebroespinhal. Ser. Inf. Tecn. OMS., Geneva, (588), 1976.

                167) NJOKU-OBI,: A. N. & AGBO, J. A. C. Meningococcal carrier rates in parts of eastern
                Nigeria Bull. WHO, Geneva, 54: 271-273, 1976.

                168) WEIBEL, R. E.; VILLAREJOS, V. M.; VELLA. P. P.; WOODHOUR, : A. F.; MCLEAN,
                A. A. & HILLEMAN, M. R. Clinical and laboratory investigations  of monovalent and
                combined meningococcal polysaccharide vaccines, groups A e C (39563). Proc. Soc. Exp.
                Biol. Med., New York, 153: , 436-440, 1976.

                169) WHITTLE, H. C.; ODULOJU, A.; EVANS-JONES, G. & GREEWOOD, B. M. Evidence
                for familial immune defect in meningococcal meningitis. Br. Med. J., London, 1: 1247-
                1250, 1976.

                170) BELCHER, D. N.; SHERRIFF, A. C.; NOMO, K. P.; CHEW, G. L.; N.; VOROS, A.
                RICHARDSON, W. D. & FELDMAN, A. A. Meningococcal meningitis in Northern GHANA:
                epidemiology and control measures. Am. J. Trop. Med. Hyg., Baltimore, 26: 748-755, 1977.
                171) BURIAN, V.; GOTSCHLICH, E.; KUZEMENSKA, P. & SVANDOVA.; E.; Naturally
                occurring antibodies to Neisseria meningitidis. Bull. WHO.; Geneva, 55: 653-657, 1977.


                                                        287
   284   285   286   287   288   289   290   291   292   293   294